Ritter stock: buy or sell?

RTTR stock price: $0.29 -6.45% At close on October 18th, 2019

Updated on:
October 18th, 2019

1

Ritter shares plunged -6.45% to $0.29 on Oct/18. On October 9th RTTR boosted a dazzling 22.86%.

Ritter Pharmaceuticals, Inc., a specialty pharmaceutical company, develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.

Should I buy Ritter stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Ritter stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Ritter Pharmaceuticals stock a buy?

Financial institutions and banks post stock ratings everyday. Unfortunately, we couldn't find any rating for RTTR stock for the last month.

Ritter stock analysis

Daily outlook

Shares of Ritter ended on Oct 18th at $0.29 and plunged a bloodcurdling -6.45%.

Ritter Pharmaceuticals plunged a bloodcurdling -6.45% and closed at $0.29. Since Sep 13th when RTTR stock price broke down the SMA200d line, it slid $-0.79 per share (-73.15%). RTTR shows a short term strength with several rising tops and rising bottoms. In the very short term, on Monday it marked a new bottom at $0.26 that should act a support if Ritter Pharmaceuticals starts a trading flat base in the range of $0.26 - $0.45 If Ritter breakouts over $0.45 with average or higher volume, this would be a clear signal that the uptrend resumes.

RTTR stock chart (daily)

Weekly outlook

After boosting a dazzling 19.35% in a week last week, Ritter closed this week at $0.29 and collapsed a scary -6.45%.

Ritter Pharmaceuticals finally declined under the support line and now is sliding further looking for new supports. Since early September, when RTTR stock price broke down the 40-weeks moving avarage line, it slid $-0.87 per share (-75.00%). Stocks below the 40-weeks moving average line are usually not recommended for average traders.

RTTR stock chart (weekly)

Ritter stock price history

Ritter stock went public on June 24th, 2015 with a price of $50.001. Since then, RTTR stock lost a -99.40%, with a yearly average of -24.90%.

1: Adjusted price after possible price splits or reverse-splits.

Ritter stock historical price chart

RTTR stock reached 52-week highs at $1.85, and all-time highs 2015-06-24 with a price of 55.

Ritter stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price prediction for Ritter stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report on March, Ritter Pharmaceuticals . Unfortunately, reported EPS is not yet available in our database.
RTTR earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.14n/a
2017-Q2-n/a-0.14n/a
2017-Q3-n/a-0.14n/a
2017-Q42018-03-19-0.5-1.1n/a
2018-Q12018-05-15-0.4-0.41n/a
2018-Q22018-08-14-0.63-0.71n/a
2018-Q32018-11-09-0.84-0.83n/a
2018-Q42019-03-29n/a-1.66n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to , last anual revenues report draw of to million dollars. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .

RTTR annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY

Quarterly financial results

Reported quarter earnings marked $-6.63 million with a profit margin of . Profit margin stayed constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Ritter sales marked a tight move and remained stable a nan%. Looking back to recent quarterly results, Ritter Pharmaceuticals posted 7 positive quarters in a row.
RTTR quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Ritter ownership

When you are planning to invest in a stock, it's worth to check its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Ritter Pharmaceuticals, 8.56% of all outstanding shares are owned by its staff.

In case of Ritter stock, 15.32% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for RTTR stock account 0.00%, no big difference from last month.

For a better context understanding, the following table shows ownership data compared to other related stocks:

RTTR
Market cap$2.7 M
Total shares9.4 M
Float shares8.0 M
  - Institutional holdings (%)15.3%
  - Insider holdings (%)8.6%
Shares in short selling0.0%

Ritter summary

Friday, October 18th, 2019
Open$0.31
Close$0.29
Day range$0.29 - $0.32
Previous close$0.31
Session gain-6.45%
Average true range$0.07
50d mov avg$0.64
100d mov avg$0.80
200d mov avg$0.80
Daily patternlb03a
Weekly pattern lt01c

Ritter performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We compared Ritter against in the following table:
Stock3m6m12m
RTTRRitter Pharmaceut...-70.71%-69.15%-82.74%

Ritter competitors

Unfortunately, we could not find any public company that could be defined as Ritter Pharmaceuticals competitor. This doesn't mean Ritter Pharmaceuticals does not have any competitor in the market, it's just we could not detected it.